ロード中...
Hepatic iron overload, a possible consequence of treatment with imatinib mesylate: a case report
Imatinib, a tyrosine kinase inhibitor has revolutionized the therapy of Philadelphia chromosome positive chronic myeloid leukemia. Side effects of imatinib include grade 1-4 hepatotoxicity in a subset of patients. We report the case of a 46-year-old male with chronic myeloid leukemia, who developed...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cases Network Ltd
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2740313/ https://ncbi.nlm.nih.gov/pubmed/19829996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1757-1626-2-7526 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|